EFFICACY, SAFETY, PHARMACOKINETICS AND PHARMACODYNAMICS OF THE ANTI-CD40 MONOCLONAL ANTIBODY ISCALIMAB (CFZ533) IN DE NOVO LIVER TRANSPLANT RECIPIENTS: RATIONALE AND DESIGN OF THE CONTRAIL I STUDY
Publication
, Conference
Knechtle, SJ; Saliba, F; Nashan, B; Martzloff, E-D; Espie, P; Speziale, A; Feng, S
Published in: TRANSPLANT INTERNATIONAL
October 1, 2019
Duke Scholars
Published In
TRANSPLANT INTERNATIONAL
EISSN
1432-2277
ISSN
0934-0874
Publication Date
October 1, 2019
Volume
32
Start / End Page
341 / 341
Publisher
WILEY
Related Subject Headings
- Surgery
- 3202 Clinical sciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Knechtle, S. J., Saliba, F., Nashan, B., Martzloff, E.-D., Espie, P., Speziale, A., & Feng, S. (2019). EFFICACY, SAFETY, PHARMACOKINETICS AND PHARMACODYNAMICS OF THE ANTI-CD40 MONOCLONAL ANTIBODY ISCALIMAB (CFZ533) IN DE NOVO LIVER TRANSPLANT RECIPIENTS: RATIONALE AND DESIGN OF THE CONTRAIL I STUDY. In TRANSPLANT INTERNATIONAL (Vol. 32, pp. 341–341). WILEY.
Knechtle, Stuart J., Faouzi Saliba, Bjorn Nashan, El-Djouher Martzloff, Pascal Espie, Antonio Speziale, and Sandy Feng. “EFFICACY, SAFETY, PHARMACOKINETICS AND PHARMACODYNAMICS OF THE ANTI-CD40 MONOCLONAL ANTIBODY ISCALIMAB (CFZ533) IN DE NOVO LIVER TRANSPLANT RECIPIENTS: RATIONALE AND DESIGN OF THE CONTRAIL I STUDY.” In TRANSPLANT INTERNATIONAL, 32:341–341. WILEY, 2019.
Knechtle SJ, Saliba F, Nashan B, Martzloff E-D, Espie P, Speziale A, et al. EFFICACY, SAFETY, PHARMACOKINETICS AND PHARMACODYNAMICS OF THE ANTI-CD40 MONOCLONAL ANTIBODY ISCALIMAB (CFZ533) IN DE NOVO LIVER TRANSPLANT RECIPIENTS: RATIONALE AND DESIGN OF THE CONTRAIL I STUDY. In: TRANSPLANT INTERNATIONAL. WILEY; 2019. p. 341–341.
Knechtle, Stuart J., et al. “EFFICACY, SAFETY, PHARMACOKINETICS AND PHARMACODYNAMICS OF THE ANTI-CD40 MONOCLONAL ANTIBODY ISCALIMAB (CFZ533) IN DE NOVO LIVER TRANSPLANT RECIPIENTS: RATIONALE AND DESIGN OF THE CONTRAIL I STUDY.” TRANSPLANT INTERNATIONAL, vol. 32, WILEY, 2019, pp. 341–341.
Knechtle SJ, Saliba F, Nashan B, Martzloff E-D, Espie P, Speziale A, Feng S. EFFICACY, SAFETY, PHARMACOKINETICS AND PHARMACODYNAMICS OF THE ANTI-CD40 MONOCLONAL ANTIBODY ISCALIMAB (CFZ533) IN DE NOVO LIVER TRANSPLANT RECIPIENTS: RATIONALE AND DESIGN OF THE CONTRAIL I STUDY. TRANSPLANT INTERNATIONAL. WILEY; 2019. p. 341–341.
Published In
TRANSPLANT INTERNATIONAL
EISSN
1432-2277
ISSN
0934-0874
Publication Date
October 1, 2019
Volume
32
Start / End Page
341 / 341
Publisher
WILEY
Related Subject Headings
- Surgery
- 3202 Clinical sciences
- 1103 Clinical Sciences